For decades, treatment of Parkinson’s disease has centered on replacing dopamine, the neurotransmitter whose decline drives ...

VALBY, Denmark - H. Lundbeck A/S announced today that phase 1b trial data for Lu AF28996, an investigational treatment for advanced Parkinson’s disease, will be presented at the 2026 Alzheimer’s and ...

Scientists at Florida International University have developed a promising new compound that could slow the progression of ...

Aspen's sasineprocel is an autologous induced pluripotent stem cell (iPSC) derived dopaminergic neuron precursor cell (DANPC) ...

To model tumor biology, Emulate’s platform introduces stromal contents by tuning the extracellular matrix stiffness and composition, as well as recreating essential gradients. The method captures ...

Research from FIU scientists have discovered a promising new compound that could slow the progression of Parkinson's disease ...

Northwestern Medicine scientists have discovered an FDA-approved compound promotes neuroprotective effects in experimental models of Parkinson’s disease, according to a recent study published in The ...

Known early on for skin-baring temptress roles, she later earned rave reviews, a Cannes award and an Oscar nomination for her ...

Sasineprocel’s encouraging Phase I/IIa data positions autologous iPSC-derived dopaminergic neuron therapy as a potential monotherapy challenger in Parkinson’s disease (PD), signaling a shift toward ...

Q. I take pramipexole to treat restless leg syndrome. When I play casinos, I seem not to be able to stop playing. I have almost maxed out my credit cards.My doctor said a drug I was taking could cause ...